Medicinal Products

Thursday, 26 September 2024

Questions (308)

Mary Lou McDonald

Question:

308. Deputy Mary Lou McDonald asked the Minister for Health if semaglutide is licenced and approved for use for insulin resistance or weight management or any other purpose in the State; if it is approved or under consideration for reimbursement in any context other than type 2 diabetes; and if he will make a statement on the matter. [38430/24]

View answer

Written answers

Minister for Health (Deputy Stephen Donnelly)

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.